Mono Pharmacare IPO
IPO Details
- Open Date
28 Aug 2023
- Close Date
30 Aug 2023
- IPO Price Range
₹ 26 to ₹ 28
- IPO Size
₹ 14.84 Cr
- Listing Exchange
NSE SME
- Listing Date
07 Sep 2023
IPO Timeline
Mono Pharmacare IPO Subscription Status
Date | QIB | NII | Retail | TOTAL |
---|---|---|---|---|
28-Aug-23 | 0.00 | 0.19 | 3.37 | 1.60 |
29-Aug-23 | 0.04 | 0.75 | 8.25 | 4.06 |
30-Aug-23 | 10.89 | 8.00 | 19.40 | 13.42 |
Last Updated: 03 January 2024 8:57 PM by 5Paisa
Mono Pharmacare Ltd. IPO is all set to open from 28th August to 30th August 2023. The company markets and distributes pharma products. The IPO includes a fresh issue of 53,00,000 shares worth ₹14.84 cr. The share allotment date is 4th September, and the IPO will be listed on 7th September on the stock exchanges. The price band is ₹26 to ₹28 per share and the lot size is 4000 shares.
Unistone Capital Private Limited is the book-running lead manager for this IPO, while Bigshare Services Private Limited is the registrar.
Objectives of Mono Pharmacare IPO:
Mono Pharmacare Limited plans to utilize the raised capital from the IPO to:
● Fulfill the working capital requirements
● For general corporate purposes
● To fund the public issue
Established in 1994, Mono Pharmacare operates in the pharmaceutical industry, functioning as both a pharmaceutical product marketer and a distributor for various pharmaceutical companies. They engage with contract manufacturers to produce pharmaceutical products according to specified compositions, which are marketed under the company’s own brand, "DLS Export." Additionally, Mono Pharmacare serves as a distributor for multiple pharmaceutical companies.
As of February 2023, Mono Pharmacare has established relationships with 168 pharmaceutical companies, including distributors and stockists, while also maintaining connections with 3,036 customers and vendors. This extensive network includes a diverse mix of retail pharmacy stores and wholesalers.
The company’s product portfolio includes a wide variety of drugs, including Antibiotics, Antifungal medications, Anti-Cough and Cold remedies, Anti-allergic treatments, Antacids, Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare products, Antiseptics, Cardiac medications, Diabetic treatments, Cosmetics, etc.
Peer Comparison
● Chandra Bhagat Pharma Limited
For More Information:
Webstory on Mono Pharmacare IPO
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Revenue | 58.45 | 36.98 | 28.26 |
EBITDA | 2.97 | 1.28 | 0.85 |
PAT | 1.23 | 0.35 | 0.095 |
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Total Assets | 81.09 | 14.38 | 11.22 |
Share Capital | 12.37 | 4.30 | 4.28 |
Total Borrowings | 63.11 | 10.10 | 7.53 |
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Net cash generated from / (used in) operating activities | -38.95 | 0.24 | -0.78 |
Net cash from / (used in) investing activities | -1.22 | -0.014 | -0.064 |
Net cash flow from / (used in) financing activities | 40.34 | -0.15 | 0.67 |
Net increase (decrease) in cash and cash equivalents | 0.17 | 0.071 | 0.18 |
Strengths
1. Experienced promoters and management.
2. Scalable business model and competitive products
3. Planning to expand product portfolio and expansion in different geographies.
Risks
1. Relies on the third party for product manufacturing.
2. High volume, low margin business.
3. Certain contingent liabilities can impact its business operations.
4. High working capital requirement.
5. The business is currently concentrated in Ahmedabad, Gujarat.
in 3easy steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
FAQs
The minimum lot size of Mono Pharmacare IPO is 4000 shares and the investment required is ₹1,04,000.
The price band of Mono Pharmacare IPO is ₹26 to ₹28 per share.
Mono Pharmacare IPO opens from 28th August to 30th August 2023.
The size of Mono Pharmacare IPO is ₹14.84 cr.
The share allotment date of Mono Pharmacare IPO is 4th September 2023.
The Mono Pharmacare IPO will be listed on 7th September 2023.
Unistone Capital Private Limited is the book-running lead manager for Mono Pharmacare IPO.
Mono Pharmacare Ltd. plans to utilize the raised capital from the IPO to:
1. Fulfill the working capital requirements
2. For general corporate purposes
3. To fund the public issue
To apply for Mono Pharmacare IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Mono Pharmacare Ltd. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
● You will receive a mandate notification to block funds in your UPI app.
Contact Information
Mono Pharmacare
Mono Pharmacare Limited
1A, Krinkal Apartment Opp.
Mahalaxmi Temple, Paldi
Ahmedabad -380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Mono Pharmacare IPO Register
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Mono Pharmacare IPO Lead Manager
Unistone Capital Pvt Ltd.